supraclavicular brachial plexus block using nalbuphine levobupivicaine vs levobupivicaine alone in orthopaedic surgeries
Not Applicable
- Conditions
- Health Condition 1: M849- Disorder of continuity of bone, unspecifiedHealth Condition 2: M849- Disorder of continuity of bone, unspecifiedHealth Condition 3: M849- Disorder of continuity of bone, unspecified
- Registration Number
- CTRI/2022/06/043123
- Lead Sponsor
- JLN medical College ajmer
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
age group 18 to 60 yr
Exclusion Criteria
pt not willing to participate in study
uncooperative patients any known hypersensitivity or contraindication to levobupivicaine or nalbuphine
local pathology at the site of block
patients with bleeding or clotting disorder,history of convulsion allergy to the drug used
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess and compare the analgesic effect in both the groups <br/ ><br>to assess and compare the haemdynamic changes in both the groupsTimepoint: 1 year
- Secondary Outcome Measures
Name Time Method to asses and compare EFFICACY OF NALBUPHINE - LEVOBUPIVICAINE COMBINATION WITH LEVOBUPIVICAINE ALONE IN USG GUIDED SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK IN UPPER LIMB ORTHOPAEDIC SURGERIESTimepoint: around 1 year